Treatment of metastatic malignant melanoma during pregnancy with a BRAF kinase inhibitor

ConclusionMalignancy during pregnancy poses both medical and ethical dilemmas in the management and treatment of cancer. The treatment of late-stage melanoma in pregnancy with a BRAF kinase inhibitor may be an option.
Source: Case Reports in Womens Health - Category: OBGYN Source Type: research